A Short-term Administration Study of Aripiprazole in Children and Adolescents (Age: 6 to 17 Years) With Autistic Disorder
Phase of Trial: Phase III
Latest Information Update: 13 Apr 2017
At a glance
- Drugs Aripiprazole (Primary)
- Indications Autistic disorder
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 25 Oct 2016 Status changed from active, no longer recruiting to completed.
- 05 Nov 2015 Status changed from recruiting to active, no longer recruiting as per NCT.
- 04 Nov 2015 Planned End Date changed from 1 Jun 2015 to 1 Jun 2016 as per NCT